共 50 条
[41]
A Phase I study to evaluate the pharmacokinetics of axitinib (AG-13736) in healthy Chinese volunteers
[J].
Chen, Y.
;
Jiang, J.
;
Zhang, J.
;
Tortorici, M. A.
;
Pithavala, Y. K.
;
Lu, L.
;
Ni, G.
;
Hu, P.
.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS,
2011, 49 (11)
:679-687

Chen, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Oncol, San Diego, CA USA Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Jiang, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Zhang, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Tortorici, M. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Oncol, San Diego, CA USA Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Pithavala, Y. K.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Oncol, San Diego, CA USA Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Lu, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer, Beijing, Peoples R China Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Ni, G.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, New London, CT USA Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

Hu, P.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[42]
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophrenia
[J].
Yin, Wei
;
Han, David
;
Khudyakov, Polyna
;
Behrje, Rhett
;
Posener, Joel
;
Laurenza, Antonio
;
Arkilo, Dimitrios
.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,
2022, 88 (08)
:3872-3882

Yin, Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA

Han, David
论文数: 0 引用数: 0
h-index: 0
机构:
Parexel, Glendale, CA USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA

Khudyakov, Polyna
论文数: 0 引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA

Behrje, Rhett
论文数: 0 引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA

Posener, Joel
论文数: 0 引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA

Laurenza, Antonio
论文数: 0 引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA

Arkilo, Dimitrios
论文数: 0 引用数: 0
h-index: 0
机构:
Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA Takeda Pharmaceut Co Ltd, 35 Landsdowne St, Cambridge, MA 02139 USA
[43]
A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants
[J].
Gupta, Pranav
;
Chatterjee, Manash
;
Kim, Yeonil
;
Deschamps, Kathleen
;
Lemoine, Lieselotte
;
Van Dyck, Kristien
;
Matthews, Catherine Zhou
;
Rottey, Sylvie
;
Stoch, Aubrey
;
Lai, Eseng
.
INVESTIGATIONAL NEW DRUGS,
2024, 42 (05)
:492-499

Gupta, Pranav
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA

Chatterjee, Manash
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA

Kim, Yeonil
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA

Deschamps, Kathleen
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA

Lemoine, Lieselotte
论文数: 0 引用数: 0
h-index: 0
机构:
MSD Europe Belgium SRL, Brussels, Belgium Merck & Co Inc, Rahway, NJ 07065 USA

Van Dyck, Kristien
论文数: 0 引用数: 0
h-index: 0
机构:
MSD Europe Belgium SRL, Brussels, Belgium Merck & Co Inc, Rahway, NJ 07065 USA

Matthews, Catherine Zhou
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA

Rottey, Sylvie
论文数: 0 引用数: 0
h-index: 0
机构:
Ghent Univ Hosp, Ghent, Belgium Merck & Co Inc, Rahway, NJ 07065 USA

Stoch, Aubrey
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA

Lai, Eseng
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Rahway, NJ 07065 USA Merck & Co Inc, Rahway, NJ 07065 USA
[44]
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects
[J].
Liu, Yun
;
Yu, Chengyin
;
Zhang, Yifan
;
Xie, Zhifu
;
Wang, Yating
;
Qian, Hongjie
;
Liang, Liyu
;
Liu, Yanmei
;
Chen, Qian
;
Jia, Jingying
;
Yan, Sai
;
Lai, Xiaoyin
;
Li, Wei
;
Li, Jingya
;
Zhang, Yangming
;
Nan, Fajun
;
Yu, Chen
.
DRUG DESIGN DEVELOPMENT AND THERAPY,
2025, 19
:1783-1794

Liu, Yun
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Yu, Chengyin
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Zhang, Yifan
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Xie, Zhifu
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Wang, Yating
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Qian, Hongjie
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Liang, Liyu
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Liu, Yanmei
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Chen, Qian
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Jia, Jingying
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China
Shanghai Engn Res Ctr, Phase Clin Res & Qual Consistency Evaluat Drugs 1, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Yan, Sai
论文数: 0 引用数: 0
h-index: 0
机构:
Burgeon Therapeut Co Ltd, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Lai, Xiaoyin
论文数: 0 引用数: 0
h-index: 0
机构:
Burgeon Therapeut Co Ltd, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Li, Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Burgeon Therapeut Co Ltd, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Li, Jingya
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Zhang, Yangming
论文数: 0 引用数: 0
h-index: 0
机构:
Burgeon Therapeut Co Ltd, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

Nan, Fajun
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China Fudan Univ, Shanghai Xuhui Cent Hosp, Zhongshan Xuhui Hosp, Zhongshan, Shanghai, Peoples R China

论文数: 引用数:
h-index:
机构:
[45]
A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers
[J].
Zhao, Caiyun
;
Lv, Yuan
;
Wei, Minji
;
Li, Xiangyan
;
Hou, Fang
;
Wang, Jin
;
Ma, Xuzhu
;
Kang, Zisheng
;
Mao, Wei
;
Liu, Yan
;
Xia, Yahong
;
Tian, Jihong
.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
2018, 62 (12)

Zhao, Caiyun
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Lv, Yuan
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Wei, Minji
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Li, Xiangyan
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Hou, Fang
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Wang, Jin
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Ma, Xuzhu
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Kang, Zisheng
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Mao, Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Pharmaceut Co Ltd, Taizhou, Zhejiang, Peoples R China
Peking Univ, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Liu, Yan
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Xia, Yahong
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China

Tian, Jihong
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China Peking Univ, Hosp 1, Inst Clin Pharmacol, Beijing, Peoples R China
[46]
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers
[J].
Peng, Hengxin
;
Zhang, Wenjun
;
Lin, Yanqing
;
Li, Huiming
;
Qin, Suofu
.
INFECTIOUS DISEASES AND THERAPY,
2024, 13 (09)
:2053-2070

Peng, Hengxin
论文数: 0 引用数: 0
h-index: 0
机构:
Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China

Zhang, Wenjun
论文数: 0 引用数: 0
h-index: 0
机构:
Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China

Lin, Yanqing
论文数: 0 引用数: 0
h-index: 0
机构:
Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China

Li, Huiming
论文数: 0 引用数: 0
h-index: 0
机构:
Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China

Qin, Suofu
论文数: 0 引用数: 0
h-index: 0
机构:
Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China Kexing Biopharm Co Ltd, Ctr Res & Dev, Clin Program, Shenzhen 518057, Peoples R China
[47]
A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects
[J].
Ermer, James
;
Martin, Patrick
;
Corcoran, Mary
;
Matsuo, Yumiko
.
NEUROPSYCHOPHARMACOLOGY REPORTS,
2020, 40 (01)
:16-29

Ermer, James
论文数: 0 引用数: 0
h-index: 0
机构:
Shire, Wayne, PA USA
Pharmacol Dev Serv, Eagleville, PA USA Shire, Wayne, PA USA

Martin, Patrick
论文数: 0 引用数: 0
h-index: 0
机构:
Shire, 300 Shire Way, Lexington, MA 02421 USA Shire, Wayne, PA USA

Corcoran, Mary
论文数: 0 引用数: 0
h-index: 0
机构:
Shire, 300 Shire Way, Lexington, MA 02421 USA Shire, Wayne, PA USA

Matsuo, Yumiko
论文数: 0 引用数: 0
h-index: 0
机构:
Shion & Co Ltd, Osaka, Japan Shire, Wayne, PA USA
[48]
Effect of food on the single-dose pharmacokinetics and tolerability of savolitinib in Chinese healthy volunteers
[J].
Ding, Qichen
;
Ou, Meixian
;
Zhu, Huijuan
;
Wang, Yijun
;
Jia, Jingying
;
Sai, Yang
;
Chen, Qian
;
Wang, Jian
.
FUNDAMENTAL & CLINICAL PHARMACOLOGY,
2022, 36 (01)
:210-217

Ding, Qichen
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
Shanghai Engn Res Ctr Phase I Clin Res & Qual Con, Shanghai, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Ou, Meixian
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
Shanghai Engn Res Ctr Phase I Clin Res & Qual Con, Shanghai, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Zhu, Huijuan
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
Shanghai Engn Res Ctr Phase I Clin Res & Qual Con, Shanghai, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Wang, Yijun
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
Shanghai Engn Res Ctr Phase I Clin Res & Qual Con, Shanghai, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Jia, Jingying
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
Shanghai Engn Res Ctr Phase I Clin Res & Qual Con, Shanghai, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Sai, Yang
论文数: 0 引用数: 0
h-index: 0
机构:
Hutchison Medipharma Ltd, Bldg 4,720 Cailun Rd,Zhangjiang Hitech Pk, Shanghai 201203, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Chen, Qian
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
Shanghai Engn Res Ctr Phase I Clin Res & Qual Con, Shanghai, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China

Wang, Jian
论文数: 0 引用数: 0
h-index: 0
机构:
Hutchison Medipharma Ltd, Bldg 4,720 Cailun Rd,Zhangjiang Hitech Pk, Shanghai 201203, Peoples R China Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China
[49]
Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study
[J].
Xu, Jia
;
Zhang, Hong
;
Chen, Hong
;
Zhu, Xiaoxue
;
Jia, Haiyan
;
Xu, Zhongnan
;
Huo, Dandan
;
Zhang, Hong
;
Li, Cuiyun
;
Ding, Yanhua
.
ANNALS OF MEDICINE,
2023, 55 (02)

Xu, Jia
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Zhang, Hong
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China
Chia Tai Tianqing Pharmaceut Grp Co Ltd, Nanjing, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Chen, Hong
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Zhu, Xiaoxue
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Jia, Haiyan
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Xu, Zhongnan
论文数: 0 引用数: 0
h-index: 0
机构:
Chia Tai Tianqing Pharmaceut Grp Co Ltd, Nanjing, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Huo, Dandan
论文数: 0 引用数: 0
h-index: 0
机构:
Chia Tai Tianqing Pharmaceut Grp Co Ltd, Nanjing, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Zhang, Hong
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China
Chia Tai Tianqing Pharmaceut Grp Co Ltd, Nanjing, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Li, Cuiyun
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun 130000, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China

Ding, Yanhua
论文数: 0 引用数: 0
h-index: 0
机构:
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China
Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun 130000, Peoples R China Jilin Univ, Hosp 1, Phase Clin Trial Unit 1, Changchun, Peoples R China
[50]
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects
[J].
Ma, Junlong
;
Huang, Jie
;
Zou, Chan
;
Wu, Qian
;
Xie, Jinlian
;
Zhang, Xingfei
;
Yang, Xiaoyan
;
Yang, Shuang
;
Wu, Ziteng
;
Jiang, Yan
;
Yu, Sen
;
Zhang, Xuqing
;
Yang, Guoping
;
Li, Mingyuan
.
DRUG DESIGN DEVELOPMENT AND THERAPY,
2023, 17
:2303-2313

Ma, Junlong
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China
Hubei Univ Med, Taihe Hosp, Shiyan 442000, Hubei, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Huang, Jie
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Zou, Chan
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Wu, Qian
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Xie, Jinlian
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Zhang, Xingfei
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Yang, Xiaoyan
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Yang, Shuang
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Wu, Ziteng
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Delova Biotech Co Ltd, Nanjing 210042, Jiangsu, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Jiang, Yan
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Delova Biotech Co Ltd, Nanjing 210042, Jiangsu, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Yu, Sen
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Delova Biotech Co Ltd, Nanjing 210042, Jiangsu, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Zhang, Xuqing
论文数: 0 引用数: 0
h-index: 0
机构:
King eagle Med Co Ltd, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Yang, Guoping
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China
Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China

Li, Mingyuan
论文数: 0 引用数: 0
h-index: 0
机构:
Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China Cent South Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China